Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: J Urol. 2014 Aug 20;193(2):513–518. doi: 10.1016/j.juro.2014.08.081

Table 6.

Multivariate analysis for presence of teratoma in RPLND specimen for pre-RPLND lymph nodes ≤1.1 cm (n= 190)

Variable OR 95% CI p-value
 Clinical Stage
  I Ref
  IIa 1.2 0.3, 4.5 0.8
  IIb/c 0.5 0.1, 1.6 0.2
  III 0.5 0.1, 2.0 0.3
 Any Yolk Sac 1.0 0.4, 2.4 0.9
 Any Teratoma 2.5 1.1, 5.6 0.02
 Pre-surgery RP node size (0.1 cm increment) 1.0 0.9, 1.1 0.5
 Year of surgery (before 1999 vs. after 1999) 0.4 0.2, 1.1 0.09
 Chemotherapy (EP vs. BEP) 4.6 1.1, 17 0.03